Compare AAON & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AAON | LNTH |
|---|---|---|
| Founded | 1988 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6B | 6.5B |
| IPO Year | 1995 | 2014 |
| Metric | AAON | LNTH |
|---|---|---|
| Price | $132.79 | $100.69 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 6 |
| Target Price | ★ $107.75 | $87.00 |
| AVG Volume (30 Days) | ★ 1.4M | 1.0M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.46% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.48 | ★ 1.80 |
| Revenue | ★ $1,442,076,000.00 | $343,374,000.00 |
| Revenue This Year | $21.49 | N/A |
| Revenue Next Year | $13.70 | $14.19 |
| P/E Ratio | $299.45 | ★ $57.12 |
| Revenue Growth | ★ 20.11 | 3.62 |
| 52 Week Low | $62.00 | $47.27 |
| 52 Week High | $150.46 | $103.75 |
| Indicator | AAON | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 52.89 | 65.83 |
| Support Level | $87.14 | $91.65 |
| Resistance Level | $149.00 | $102.66 |
| Average True Range (ATR) | 7.25 | 3.38 |
| MACD | -1.43 | 0.00 |
| Stochastic Oscillator | 22.61 | 77.09 |
AAON Inc is a manufacturer of air-conditioning and heating equipment. The products include rooftop units, chillers, packaged outdoor mechanical rooms, air-handling units, makeup air units, energy-recovery units, condensing units, geothermal heat pumps, and self-contained units and coils. The company operates through three segments: AAON Oklahoma, AAON Coil Products, and BASX. It generates the majority of its revenue from the AAON Oklahoma segment which derives maximum revenue, engineers, manufactures, and sells, semi-custom, and custom HVAC systems, designs and manufactures control solutions, and sells retail parts to customers through retail part stores and online.
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.